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1. Introduction
  Diabetes mellitus (DM) is a metabolic disease characterized 
by hyperglycemia resulting from defects in insulin 
secretion, insulin action or both; also, hyperglycemia 
is still considered as the principal cause of diabetic 
complications[1,2]. Sustained higher levels of blood glucose 
cause damage to nerves and blood vessels, leading to 
complications such as erectile dysfunction[3-5]. Erectile 
dysfunction (ED) is defined as the inability of the male 
to attain and maintain erection of penis sufficient to 
permit satisfactory sexual intercourse[6]. DM is one of 
the predominant risk factors of ED and also one of the 
most difficult to treat[7]. Diabetes mellitus may cause 
erectile dysfunction through a number of pathophysiologic 
changes, including neuropathy, endothelial dysfunction, 
cavernosal smooth muscle structural/functional changes, 
hormonal changes[8,9]. Although pathophysiologic changes 
may be more pronounced in type 1 diabetes than in type 
2, they are mainly due to oxidative stress, through the 
formation of oxygen free radicals and advanced glycation 
end-products (AGEs)[10]. Oxygen free radicals and AGEs 
have been shown to contribute to the neurodegeneration, 
reduction of endothelium-dependent vasorelaxation by 
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altering the endothelial nitric oxide synthase synthesis 
and have been associated with impaired endothelium-
dependent vasodilation in Type 2 diabetic patients[11-
15]. In addition, endothelial dysfunction might be the link 
between diabetes mellitus and erectile dysfunction[16] 
since it takes a minimum of 4 weeks for a rat to develop 
erectile and nitrergic dysfunctions, whereas endothelial 
dysfunction can potentially develop in days as a direct 
consequence of hyperglycaemia[17]. Due to multiple action of 
streptozotocin intoxication, understanding how uncontrolled 
hyperglyceamia impacts the sexual function and seeking 
for efficient drugs able to alleviate diabetes-induced 
complications are yet important areas of inquiry. However, 
despite the increasing availability of effective conventional 
medical treatments for erectile dysfunction in diabetic 
patients, plant-derived and herbal remedies continue to 
provide a popular alternative for diabetic men seeking to 
improve their sexual life[18-20]. Cameroonian traditional 
medicine indicates that the mixture of the roots of Dracaena 
arborea (D. arborea)(Wild) Link (Dracaenaceae), a tall tree 
native to West Africa,  with palm wine possess aphrodisiac 
potentials. Also, in a pilot study, we demonstrated that
D. arborea extracts and especially its ethanolic extract 
(100 mg/kg) stimulate the copulatory activity of normal and 
androgen-deprived (castrated) rats through dopaminergic 
and/or cholinergic pathways[21]. The aim of the present study 
was to evaluate the aphrodisiac effects of the aqueous and 
ethanol extracts of D. arborea in streptozotocin-induced 
type 1 diabetic rats. Streptozotocin-induced type 1 diabetes 
in rats provides a relevant model to study the reproductive 
dysfunction under diabetic conditions, as they exhibit a 
number of reproductive deficits that resemble those seen in 
human diabetics[22].
2. Materials and methods 
2.1. Chemicals 
  Streptozotocin, trimethylamine-N-oxide (TMAO), estradiol 
benzoate and progesterone were purchased from Sigma 
(USA), sildenafil citrate (Kamagra®) from Ajanta Pharma 
Limited (India), diazepam from Renaudin (France), ketamine 
from Rotex Medica (Germany) and penicillin G from Clarion 
Medicals (Nigeria).
2.2. Plant material collection and preparation of extracts 
  The plant material was harvested in Bagnoun, West Region 
of Cameroon and authenticated at the Cameroon National 
Herbarium (CNH) under the voucher number 25361/SFR/Cam. 
The harvested fresh root barks were cut into small pieces, 
dried at room temperature and ground into a fine powder. 
For the aqueous extraction, eight hundred grams (800 g) of 
the powdered roots were dissolved in 5 L of distilled water 
and kept for 72 h at 25 曟, and occasionally stirred. After 
filtration, the filtrate was concentrated in an oven (40 曟)
to give 39.68 g of brownish residue corresponding to an 
extraction yield of 4.96%. In order to obtain the ethanolic 
extract, ground root bark (1 kg) of D. arborea was macerated 
with ethanol (95%) (5 L, 2×) for 72 h to yield, after solvent 
evaporation under reduced pressure, 30 g of a brownish 
extract corresponding to an extraction yield of 3%. The 
working extracts were prepared at a final concentration of 
100 mg/mL in distilled water. The doses used in the study 
were 100 and 500 mg/kg.
2.3. Phytochemical screening 
  Qualitative phytochemical evaluation was performed on 
aqueous and ethanolic extracts of D. arborea to determine 
the presence of flavonoids (test of Shinoda), sterols 
(Libermann Buchard test), phenols (ferric chloride test), 
alkaloids (Dragendorff test), or saponins (Saponification 
test). All these tests were performed as described by other 
authors[23].
2.4. Animals 
  A total of 176 adult healthy albino rats of Wistar strain 
of either sex (48 males and 128 females) were used for the 
present study. Rats were obtained from the animal house of 
the Faculty of Science, University of Dschang, Cameroon. 
They were maintained at room temperature with a natural 
light: dark cycle (12 h: 12 h) and provided with standard 
Laboratory rat diet and water ad libitum. The experiments 
were performed in accordance with the internationally 
accepted standard ethical guidelines for laboratory animal 
use and care as described in the European Community 
guidelines; EEC Directive 86/609/EEC, of the 24th November 
1986[24].
2.4.1. Male training procedure
  Male rats were trained for sexual experience prior to 
diabetes induction. To provide sexual experience, each male 
was allowed 1 h exposure to a receptive female rat (used as 
mating stimulator) in behavioral estrus for 5 consecutive 
days and only those exhibiting good copulatory behavior 
(active males) were selected for the study.
2.4.2. Ovariectomy
  Ovariectomy was performed following the technique of 
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Cariton[25] with minor modifications as described by Watcho 
and colleagues[21].
2.4.3. Estrus induction  
  One month after ovariectomy, female rats were brought 
into estrus by sequential subcutaneous injection of 30 毺g 
of estradiol benzoate and 600 毺g of progesterone, 48 h and 
6 h respectively before testing[21]. In ovariectomized rat, it 
was shown that estradiol benzoate induced a specific urge to 
seek contact with a sexual active male[26]. They were further 
screened with non-experimental vigorous males and only 
those exhibiting good sexual receptivity and no rejection 
behaviour were employed in the tests. 
2.4.4. Diabetes induction
  Diabetes was induced in 16 h fasted adult male rats by 
a single intraperitoneal injection of a buffered solution
(0.1 M citrate, pH 4.5) of streptozotocin at the dose 50 mg/kg.
To prevent hypoglycemia, animals were given a 10% glucose 
solution for the next 48 h. Blood glucose level was measured 
7 d after diabetes induction using reagent strips (Accu-
Chek®, Roche,). Blood was collected from tail vein and 
rats with blood glucose values more than 200 mg/dL were 
considered diabetics. Forty two rats were made diabetic 
in this way and kept for four weeks before starting the 
experiment. Initial and final fasting blood glucose levels 
were recorded in this study.
2.5. Experimental design 
  A total of 48 rats (42 diabetics and 6 non diabetic rats) 
were randomly divided into 8 groups of 6 animals each 
and treated as follows: Group 1, normal rats receiving the 
vehicle (10 mL/kg of distilled water). Group 2, diabetic rats 
receiving 10 mL/kg of distilled water. Group 3, diabetic rats 
receiving 1.44 mg/kg of sildenafil citrate. Group 4, diabetic 
rats receiving 20 mg/kg of trimethylamine-N-oxide (TMAO). 
Groups 5 and 6, diabetic rats receiving 100 mg/kg and
500 mg/kg of the aqueous extract of D. arborea. Groups 7 and 
8, diabetic rats receiving 100 mg/kg and 500 mg/kg of the 
ethanol extract of D. arborea. The vehicle (distilled water) as 
well as the reference drugs (Sildenafil citrate and TMAO) and 
plant extracts were orally administered once a day for four 
weeks. 
2.6. Sexual behavior testing procedure 
  The sexual behavior of each rat was monitored for 4 
consecutive weeks in a dark and quiet room for 1 h and 
30 min duration. After 30 min of acclimatization in the 
copulation cage (rectangular glass cage), a stimulus-
receptive female was presented to each male by dropping 
it gently into the cage. The following parameters were 
recorded by ejaculatory series according to standard 
methods[21,27]: mount (ML) and intromission latency (IL), the 
time elapsed from the introduction of a female into a cage 
until the first mount and intromission respectively; mount 
(MF) and intromission frequency (IF), the number of mounts 
and intromissions preceding ejaculation respectively in 
one series; post-ejaculatory interval (PEI), the elapsed time 
between an ejaculation and the first intromission of the next 
ejaculatory series. Further, the test was force-ended when 
ML equaled 20 min.
2.7. Statistical analysis
  Data are expressed in mean依SEM. Data from blood glucose 
levels were analysed using Two ways ANOVA followed by 
Table 1
Effects of D. arborea, sildenafil citrate and TMAO on fasting blood glucose level.
Groups Initial blood glucose level (mg/dL)            Final blood glucose level (mg/dL)
Control    52.38依5.76a    57.38依3.29a
STZ        283.67依10.57a***        399.17依44.03b***
STZ+Sildenafil        318.00依28.62a***         220.17依39.38bC **
STZ+TMAO        344.83依30.01a***        289.17依57.63a***
STZ+AQ100        416.17依44.38a***        428.83依39.20a***
STZ+AQ500        275.00依17.01a***          270.50依15.82aA***
STZ+ETH100        280.29依22.87a***          243.71依36.15aB***
STZ+ETH500        326.17依28.47a***          272.67依87.38aA***
Values of blood glucose level are means依SEM, n = 6. Control = normal rats receiving distilled water (10 mL/kg). STZ = diabetic rats receiving 
distilled water (10 mL/kg). STZ+Sildenafil = diabetic rats treated with sildenafil citrate (1.44 mg/kg). STZ+TMAO = diabetic rats treated with 
trimethylamine-N-oxide (20 mg/kg). STZ+AQ100 or AQ500 = diabetic rats treated with aqueous extract of D. arborea (100 or 500mg/kg). 
STZ+ETH100 or ETH500 = diabetic rats treated with ethanol extract of D. arborea (100 or 500 mg/kg). On the same line, the values of blood 
glucose level assigned by the same lowercase letter are not significantly different. In the same column, **P<0.01, *** P<0.001 significantly 
different compared to the corresponding normal control. Always in the same column, AP<0.05; BP<0.01, CP<0.001 significantly different 
compared to the corresponding STZ control.
Wankeu-Nya M et al./Asian Pacific Journal of Tropical Medicine (2014)609-619612
Bonferroni all pair comparism test. The effect of the duration 
of the treatment on each copulatory parameter was analyzed 
using two ways ANOVA repeated measures followed by 
Bonferroni all pair comparism test when necessary. Within 
the same week of treatment, two ways ANOVA followed by 
Bonferroni all pair comparism test was used to compare 
the treated groups to normal and diabetic control animals 
respectively. P values of 0.05 or less were taken to imply 
statistical significance between the means. All these analysis 
were performed using Graphpad Prism version 5.1.
3. Results
3.1. Phytochemical analysis
  Qualitative phytochemical screening of both aqueous 
and ethanol extracts of D. arborea dried roots showed 
the presence of saponins, phenols, flavonoids and sterols 
whereas alkaloids were absent in the two extracts.
3.2. Fasting blood glucose level
  Table 1 shows that after four weeks of treatment, apart 
Table 2
Effects of D. arborea, sildenafil citrate and TMAO on mount frequency.
Ejaculatory series Groups
Treatment period 
Week 0 Week 1 Week 2 Week 4
Series 1 Control   17.60依1.88a   9.40依1.29a 16.00依2.52a 47.20依9.17b
STZ   13.00依6.00a    3.60依3.60ab     3.60依3.60ab 0b***
STZ+ Sildenafil   20.00依1.25a        42.00依18.15abC**   35.00依7.07aB  66.00依8.53bC
STZ+TMAO   16.75依6.16a    30.75依3.73acA    28.50依5.25acA   45.25依8.36cC
STZ+AQ100   21.80依6.30a 21.60依8.05a  27.40依9.01a   11.60依3.59a**
STZ+AQ500   15.83依5.70a   30.40依8.70aA   30.20依8.39aB  29.80依9.18aB
STZ+ETH100   18.20依2.97a 22.80依5.65a   34.40依5.88aB    23.60依3.91a***
STZ+ETH500   13.40依5.51a   7.40依5.11a  11.40依4.73a   9.60依4.30a
Series 2 Control   14.00依2.28a   7.60依0.59a 13.60依2.56a 19.80依2.91a 
STZ 0a   2.60依2.60a    2.00依2.00a 0a**
STZ+ Sildenafil   13.75依8.05a   19.75依5.96aB   23.25依2.17aC  29.75依2.69aC 
STZ+TMAO     7.75依5.20a  20.25依5.17aB 14.25依4.80a  15.50依7.66aA 
STZ+AQ100     7.20依1.98a 12.60依4.15a 12.80依2.71a   8.60依2.73a
STZ+AQ500     6.00依2.60a    19.80依5.27abB    28.40依9.19bC*    15.80依3.99abA 
STZ+ETH100     5.80依1.21a 11.00依0.71a   19.40依4.10aB 13.40依2.28a
STZ+ETH500     3.80依2.33a   4.40依2.69a   5.00依3.26a    3.40依2.14a*
Series 3 Control   15.00依5.05a   8.40依1.21a  13.00依2.59a 30.00依8.26a
STZ 0a 0a    2.20依2.20a 0a***
STZ+ Sildenafil     7.50依4.41a    17.25依6.42abA    23.75依3.59abB  26.75依4.33bC
STZ+TMAO      2.72依2.75ab    9.25依3.50ab     23.50依12.90aB 0
STZ+AQ100     9.80依3.15a  10.80依5.36a  11.80依4.16a      3.00依2.00a***
STZ+AQ500     4.00依1.50a 14.80依2.74a     24.40依18.09aB    26.60依12.11aC
STZ+ETH100     2.40依1.90a 15.00依2.66b 16.80依3.21b      6.40依1.36ab**
STZ+ETH500     6.00依2.51a   5.20依3.20a 0      2.20依2.20a***
Series 4 Control 10.20依2.9a 14.40依1.93a    9.40依2.80a   6.00依4.74a
STZ 0a* 0a*** 0a* 0a
STZ+ Sildenafil 0a*   8.25依4.77a    4.25依4.25a 0a
STZ+TMAO 0a*    11.25依4.33bdA   15.25依5.56cd 0a
STZ+AQ100     1.60依1.60a     1.40依1.40a**   1.20依1.20a   4.60依2.80a
STZ+AQ500 0a*    3.40依1.95a*    1.20依1.10a  2.00依1.83a
STZ+ETH100 0a*    4.80依2.76a* 12.40依3.64a   3.80依2.16a
STZ+ETH500     2.20依2.20a     3.00依3.00a** 0a* 0a
Series 5 Control     2.00依1.58a   4.20依2.04a 0a 0a
STZ 0a 0a 0a 0a
STZ+ Sildenafil 0a 0a 0a 0a
STZ+TMAO 0a     10.75依6.92aC** 3.00依3.00a 0a
STZ+AQ100 0a 0a 0a 0a
STZ+AQ500 0a 0 0a 0a
STZ+ETH100 0a   3.40依1.69a 0a 0a
STZ+ETH500 0a 0a 0a 0a
Values of mount frequency are means依SEM (n=6).
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from the untreated diabetic rats where the blood glucose 
continued to increase significantly (P<0.05), those of all other 
groups remained statistically unchanged (P>0.05) compared 
to their respective baseline values (initial blood glucose 
level) but remained high compared to normal control rats.
3.3. Sexual behavior test
3.3.1. Effects on mount and intromission frequencies
  Tables 2 and 3 clearly indicate the tendency to decrease 
in the mount frequency (MF) and intromission frequency (IF) 
as the ejaculatory series evolved. It can also be observed 
that compared to the baseline value (week 0) and to the 
normal control group, the untreated diabetic rats showed 
a significant (P<0.05-0.001) decrease in these two sexual 
parameters particularly in the ejaculatory series 1 to 3 after 
four weeks. 
  Sildenafil citrate, TMAO, aqueous (500 mg/kg) and ethanol 
(100 mg/kg) extracts of D. arborea produced a significant 
increase (P<0.05-0.001) in the mount and intromission 
frequencies especially at the first ejaculatory series, 
on weeks 1, 2 and 4 of treatment when compared to the 
untreated diabetics and week 0. The ejaculatory series 1, 
2 and 3 were the most important in these recordings; with 
Table 3
Effects of D. arborea, sildenafil citrate and TMAO on intromission frequency.
Ejaculatory series Groups
Treatment period 
Week 0 Week 1 Week 2 Week 4
Series 1 Control 16.80依1.83a   9.40依1.29a 16.80依1.40a 46.20依9.06b
STZ 12.00依5.00a   3.40依3.40a   3.40依3.40a 0b***
STZ+ Sildenafil 18.00依1.68a       40.25依17.24abC**   34.25依6.73aC   66.00依8.53bC
STZ+TMAO 15.75依5.68a  30.25依3.71aB   26.75依3.45aB   44.25依8.25bC
STZ+AQ100 17.80依6.15a 18.20依6.42a   22.20依5.94aA     11.60依3.59a***
STZ+AQ500 15.60依5.70a  30.40依8.70aA   30.20依8.39aB   29.80依9.18aC
STZ+ETH100 15.80依1.97a 21.20依5.46a   31.40依5.57aB   18.00依2.17a**
STZ+ETH500 13.20依5.43a   9.40依5.78a 10.80依4.49a       9.20依4.09a***
Series 2 Control 13.80依2.34a   7.60依0.59a  13.20依2.42a 19.80依2.91a
STZ 0a*   2.60依2.60a   2.00依2.00a 0a***
STZ+ Sildenafil   13.75依8.05aA  19.75依5.96aB  23.25依2.17aC   29.75依2.69aC
STZ+TMAO   7.75依5.20a  20.25依5.17aB 14.25依4.80a   15.50依7.66aB
STZ+AQ100   7.20依1.98a 12.60依4.15a 12.80依2.71a   8.60依2.73a
STZ+AQ500   6.00依2.60a   19.80依5.27abA   28.40依9.19bC    15.80依3.99abA
STZ+ETH100   5.40依1.19a 10.60依0.73ab   18.40依3.86bB  11.60依1.16ab
STZ+ETH500   3.80依2.33a   4.40依2.69a   5.00依3.26a     3.40依2.14a**
Series 3 Control  13.80依1.53ab   8.20依1.31a   13.00依2.59ab 29.80依8.24b
STZ 0a 0a   2.00依2.00a 0a***
STZ+ Sildenafil   7.25依4.31a   16.25依6.03abA    23.50依3.43abB   26.75依4.33bC
STZ+TMAO    2.50依2.50ab    9.00依3.49ab     23.25依12.67aB 0a***
STZ+AQ100   8.40依3.08a   9.80依4.96a 10.00依3.58a   2.80依1.96a
STZ+AQ500   4.00依1.50a 14.80依2.74a   24.40依8.09aB     26.60依12.11aC
STZ+ETH100   2.20依1.74a 14.60依2.48b  16.00依3.18b        6.20依1.48ab***
STZ+ETH500   3.40依2.23a   5.20依3.20a 0a       2.20依2.20a***
Series 4 Control 10.00依2.92a 13.80依1.84a   9.40依2.80a   5.80依4.59a
STZ 0a* 0a*** 0a* 0a
STZ+ Sildenafil 0a*   7.75依4.52a    4.00依4.00a 0a
STZ+TMAO 0a*   11.25依4.33abB   15.25依5.56bC 0a
STZ+AQ100 0a*     1.20依1.20a**   1.00依1.00a   4.40依2.71a
STZ+AQ500 0a*     3.40依1.95a**   1.20依1.10a   2.00依1.83a
STZ+ETH100 0a*    4.20依2.45a*   11.80依3.48aB   3.80依2.16a
STZ+ETH500   2.20依2.20a    3.00依3.00a* 0a* 0a
Series 5 Control   2.00依1.58a   3.60依1.76a 0a 0a
STZ 0a 0a 0a 0a
STZ+ Sildenafil 0a 0a 0a 0a
STZ+TMAO 0a      10.75依6.92aC***   3.00依3.00a 0a
STZ+AQ100 0a 0a 0a 0a
STZ+AQ500 0a 0a 0a 0a
STZ+ETH100 0a   3.40依1.69a   1.00依0.79a 0a
STZ+ETH500 0a 0a 0a 0a
Values of intromission frequency are means依SEM (n=6).
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regard to the ejaculatory series 4 and 5, only TMAO-treated 
rats showed similar effects on week 1 compared to week 0 
(P<0.05) and to the untreated diabetic group (P<0.01-0.001) 
respectively.
3.3.2. Effects on mount and intromission latencies
  In the first four ejaculatory series, mount and intromission 
latencies were significantly increased (P<0.01-0.001) in the 
untreated diabetic group. On the contrary, when compared 
to week 0 and to the untreated diabetic animals respectively, 
especially in the first ejaculatory series of week 4, mount 
latency (ML) and intromission latency (IL) significantly 
decreased (P<0.05-0.001) after treatments with sildenafil 
citrate (75.52% and 96.31% of decrease for ML; 65.63% and 
96.31% of decrease for IL), TMAO (46.92% and 77.89% for ML; 
48.11% and 76.77% of decrease for IL), aqueous 500 mg/kg 
(88.95% and 94.33% of decrease for ML; 89.02% and 94.33% of 
decrease for IL) and ethanol 100 mg/kg (86.41% and 96.98% 
of decrease for ML; 89.08% and 97.08% of decrease for IL) 
extracts of D. arborea (Tables 4 and 5). 
3.3.3. Effects on post-ejaculatory interval
  As observed in Table 6, the post-ejaculatory interval (PEI) 
was significantly increased (P<0.05-0.001) in diabetic rats 
Table 4
Effects of D. arborea, sildenafil citrate and TMAO on mount latency.
Ejaculatory series Groups
Treatment period 
Week0 Week1 Week2 Week4
Series 1 Control      67.40依35.83a     22.60依13.95a     7.40依1.26a      17.00依8.20a
STZ    1 148.80依51.20a*** 1 200.00依0.00a***     1 008.00依192.00a***     1 200.00依0.00a***
STZ+ Sildenafil     180.75依64.00aC      52.75依16.50bC     30.75依9.22bC          44.25依30.61bC
STZ+TMAO       499.75依238.71aB    16.50依8.10bC   160.00依8.71bC           265.25依194.78abC
STZ+AQ100     177.40依21.50aC      394.20依224.15aC      6.00依1.95bC          253.60依236.61aC
STZ+AQ500       615.60依258.38aA    117.00依57.92aC     241.40依59.24aC        68.00依8.02aC
STZ+ETH100     266.40依59.85aC       70.60依16.07abC     158.40依74.59abC        36.20依5.78bC
STZ+ETH500        565.60依260.49aA*       736.20依284.20a**       612.20依255.03a**           520.60依278.00aB*
Series 2 Control    405.60依34.61a   359.60依16.55a   424.40依21.11a      632.40依33.32b
STZ    1 148.80依51.20a*** 1 200.00依0.00a***    1 008.00依192.00a**   1 200.00依0.00a**
STZ+ Sildenafil       670.25依181.75aA    495.00依55.17aC     607.50依179.93a        780.25依267.32a
STZ+TMAO       878.50依186.41a*       874.75依383.20aB*     667.50依186.49a          736.50依166.52aA
STZ+AQ100      711.40依150.47a      787.20依177.46aB     483.80依27.84aA          741.80依143.23aA
STZ+AQ500      819.20依163.50a    428.20依15.95bC      475.80依54.85abA        400.80依28.25bC
STZ+ETH100     915.60依95.65a*     559.40依82.20abC     473.00依57.42bA        436.80依45.03bC
STZ+ETH500       937.20依161.45a*        915.00依177.93aA**      966.80依167.70a*        982.20依136.75a
Series 3 Control   436.60依23.78a   466.00依22.74a   551.00依37.84a       912.2 0依240.02b
STZ  1 200.00依0.00a*** 1 200.00依0.00a***  1 200.00依0.00a*** 1 200.00依0.00a
STZ+ Sildenafil        944.00依149.20a**      861.25依116.14a*      823.75依151.92aA        925.00依173.11a
STZ+TMAO      1 104.75依95.25ab***       856.75依172.87ab*      678.75依178.59aB 1 200.00依0.00b
STZ+AQ100        890.80依102.46a**      856.00依143.50a*       762.60依118.81aC        957.40依150.27a
STZ+AQ500        951.40依116.72a**   735.8 0依67.19aB       765.00依111.75aA          681.40依75.53aB**
STZ+ETH100    1 154.00依36.35a***    715.60依98.19bB       687.20依106.92bB          373.20依79.46bC**
STZ+ETH500        937.60依161.56a**     1 014.20依123.09a*** 1 200.00依0.00a***   1 138.00依62.00a
Series 4 Control    793.60依95.95a   568.60依70.49a   948.60依96.95a    1122.00依61.66a
STZ  1200.00依0.00a**  1200.00依0.00a***  1200.00依0.00a***  1200.00依0.00a
STZ+ Sildenafil 1 200.00依0.00a**    1 045.25依106.17a**  1 151.00依49.00a** 1 200.00依0.00a
STZ+TMAO 1 200.00依0.00a**      754.00依162.51bB      880.75依133.93ab  1 200.00依0.00ab
STZ+AQ100   1 087.60依112.40a     1 073.60依126.40a***   1 089.60依110.40a*     1 119.80依151.88a
STZ+AQ500 1 200.00依0.00a**  1 030.20依95.19a**   1 072.20依116.64a*      109.80依82.32a
STZ+ETH100 1 200.00依0.00a**      949.00依123.58a*    736.00依98.91aB    1 028.60依94.76a
STZ+ETH500  1 154.60依45.40a*   1 161.40依38.60a***  1 200.00依0.00a***  1 200.00依0.00a
Series 5 Control    793.60依95.95a   568.60依70.49a  948.6 0依96.95a    1 122.00依61.66a
STZ 1 200.00依0.00a** 1 200.00依0.00a*** 1 200.00依0.00a*** 1 200.00依0.00a
STZ+ Sildenafil 1 200.00依0.00a**    1 045.25依106.17a**  1 151.00依49.00a**     200.00依0.00a
STZ+TMAO 1 200.00依0.00a**      754.00依162.51bB      880.75依133.93ab    1 200.00依0.00ab
STZ+AQ100  1 087.60依112.40a     1 073.60依126.40a***  1 089.6 0依110.40a*      1 119.80依151.88a
STZ+AQ500 1 200.00依0.00a**  1 030.20依95.19a**   1 072.20依116.64a*    1 109.80依82.32a
STZ+ETH100 1 200.00依0.00a**     949.00依123.58a*    736.00依98.91aB    1 028.60依94.76a
STZ+ETH500  1 154.60依45.40a*   1 161.40依38.60a*** 1 200.00依0.00a***  1 200.00依0.00a
Values of mount frequency are means依SEM (n=6).
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treated with distilled water during the first three ejaculatory 
series compared to normal rats. However, this parameter 
was significantly lowered (P<0.05-0.001) mostly in the first 
ejaculatory series of 4 weeks-treated diabetic rats with 
aqueous 500 mg/kg (66.60% of decrease) and ethanol 100 
mg/kg (64.26% of decrease) extracts of D. arborea. A lack of 
ejaculatory activity was noticed in the series 4 and 5.
4. Discussion
  Streptozotocin has long been used as a tool for creating 
experimental diabetes in animal. An advantage of the 
streptozotocin-model is that it closely mimics type 1 
diabetes in humans rather than type 2[2,28]. Sustained 
hyperglycemia is one of the main causes of sexual 
dysfunction[29]. Hypogonadism, neuropathy, arterial 
insufficiency, progressive loss of both endothelium and 
smooth muscle tissue, and impaired regulation of smooth 
muscle tone are the most common predictors of erectile 
dysfunction in patients or animals with diabetes[9,30]. In our 
previous article, we have shown through electron micrograph 
examinations that, streptozotocin-induced diabetes in 
rats caused testicular dysfunction, leading to the dramatic 
Table 5
Effects of D. arborea, sildenafil citrate and TMAO on intromission latency.
Ejaculatory series Groups
Treatment period 
Week0 Week1 Week2 Week4
Series 1 Control        67.80依36.14a       22.60依13.95a         7.40依1.26a      17.00依8.20a
STZ       1 159.40依40.60a***    1200.00依0.00a***           1008.00依192.00a***      1200.00依0.00a***
STZ+ Sildenafil        128.75依44.58aC         52.75依16.50bC         30.75依9.22bC          44.25依30.61bC
STZ+TMAO          537.25依221.64aB       16.50依8.10bC         16.00依8.71bC            278.75依208.01abC
STZ+AQ100        199.80依23.29aC        429.00依220.11aC           6.00依1.95bC          253.60依236.61aC
STZ+AQ500           619.40依256.80aA*      133.00依53.11aC         244.80依59.16aC        68.00依8.02aC
STZ+ETH100      320.60依50.91a        97.80依9.72abC          158.40依74.59abC        35.00依7.31bC
STZ+ETH500           606.80依242.36aA*         736.20依284.02a**            690.80依261.12a**          520.60依278.00aB*
Series 2 Control      405.60依34.61a       359.60依163.55a       424.60依20.96a      632.40依33.32b
STZ    1 200.00依0.00a***        1056.80依143.20a***          1030.40依169.60a**    1200.00依0.00a**
STZ+ Sildenafil         846.75依196.33a*      495.00依55.17aB           582.50依154.95aA        780.25依267.32a
STZ+TMAO         878.50依186.41a*        874.75依383.20a*         667.50依186.49a          736.50依166.52aA
STZ+AQ100         732.80依143.46aA       796.20依173.91a         505.20依36.09aA        774.40依136.73a
STZ+AQ500        819.20依163.50a       437.60依16.24bB          475.80依54.85abB        400.80依28.25bC
STZ+ETH100       847.00依90.21a*        559.40依82.20abA         473.60依57.21bB        452.20依42.73bC
STZ+ETH500           947.40依156.11a**         915.00依177.93a**            968.40依167.03a**        982.20依136.75a
Series 3 Control      476.60依24.91a     466.00依22.74a       551.00依37.84a     1 152.20依158.73b
STZ    1 200.00依0.00a***   1 200.00依0.00a***      1 200.00依0.00a*** 1 200.00依0.00a
STZ+ Sildenafil       945.500依148.52a*       811.25依140.34a           823.75依151.92aC        925.00依173.11a
STZ+TMAO        1 104.75依95.25ab***       857.25依172.95a           678.75依178.59aC  1 200.00依0.00b
STZ+AQ100           920.2依101.56a*      857.20依142.9ab           764.60依118.23aC        959.00依149.12a
STZ+AQ500          972.20依119.95a**      738.40依66.56aA           756.80依115.93aC        681.40依75.53aB
STZ+ETH100      1 154.00依36.35a***      715.60依98.19bA           668.40依106.66bC          767.20依142.53bA
STZ+ETH500         938.00依161.35a*      1 014.20依123.09a**     1 200.00依0.00a***   1 138.00依62.00a
Series 4 Control      793.60依95.95a     568.60依70.49a       948.60依96.95a   1 122.00依61.66a
STZ   1 200.00依0.00a**   1 200.00依0.00a***  1 200 .00依0.00a 1 200.00依0.00a
STZ+ Sildenafil   1 200.00依0.00a**       1 045.25依106.17a***    1 151.00依49.00a 1 200.00依0.00a
STZ+TMAO   1 200.00依0.00a**        754.00依162.51bB            880.75依133.93abA  1 200.00依0.00ab
STZ+AQ100     1 099.60依100.40a       1 073.60依126.40a***      1 090.40依109.60a     1 119.80依151.88a
STZ+AQ500   1 200.00依0.00a**    1 031.40依94.59a**      1 072.20依116.64a    1 109.80依82.32a
STZ+ETH100    1 200.00依0.00a**        951.80依122.49a*         740.20依98.86aB   1 028.60依94.76a
STZ+ETH500    1 154.60依45.40a*     1 161.40依38.60a***  1 200.00依0.00a 1 200.00依0.00a
Series 5 Control   1 138.00依49.02a 1 050.40依76.22a  1 200.00依0.00a 1 200.00依0.00a
STZ 1 200.00依0.00a 1 200.00依0.00a*  1 200.00依0.00a 1 200.00依0.00a
STZ+ Sildenafil 1 200.00依0.00a 1 200.00依0.00a*   1 200.00依0.0 0a 1 200.00依0.00a
STZ+TMAO 1 200.00依0.00a        970.00依138.11aC      1 075.75依124.25a 1 200.00依0.00a
STZ+AQ100 1 200.00依0.00a 1 200.00依0.00a*  1 200.00依0.00a 1 200.00依0.00a
STZ+AQ500 1 200.00依0.00a 1 200.00依0.00a*  1 200.00依0.00a 1 200.00依0.00a
STZ+ETH100 1 200.00依0.00a  1 079.00依58.94a  1 200.00依0.00a 1 200.00依0.00a
STZ+ETH500 1 200.00依0.00a 1 200.00依0.00a*  1 200.00依0.00a 1 200.00依0.00a
Values of intromission frequency are means依SEM (n=6).
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changes in the testicular morphology and the alteration of 
spermatogenic process which were corrected by D. arborea 
treatment[31]. The main objective of this work was to evaluate 
the effect of D. arborea on the sexual behavior of 4 weeks 
hyperglycemic rats. In the present work, we show that an 
intraperitoneal injection of streptozotocin to rats always 
brought out severe hyperglycemia. However, the minor drop 
of glycemia observed 4 weeks after various treatments is of 
less importance since all recorded glycemic values were 
within the range of the pre-defined glycemic status (>200 
mg/dL).
  As expected, an impairment of the sexual function of 
the untreated diabetic rats was noticed under diabetic 
condition; this sexual dysfunction was indicated by a 
significant decrease in the sexual performance/vigor 
parameters (frequency of mounts and intromission) whereas 
an increase in the sexual motivation parameters (latency 
of mount and intromission, post-ejaculatory interval) was 
observed. It is known that diabetes has the potential to 
impact all components of the erectile response in patients 
and in the streptozotocin-induced diabetic rat model. These 
deleterious effects of diabetes in the copulatory activity 
of rats could be due to the impairment in smooth muscle 
relaxation leading to the decrease of the arterial inflow in 
Table 6
Effects of D. arborea, sildenafil citrate and TMAO on post-ejaculatory interval.
Ejaculatory series Groups
Treatment period 
Week0 Week1 Week2 Week4
Series 1 Control     405.60依34.61a       =359.60依16.55a      424.60依20.96a      632.40依33.32b
STZ       1 066.00依134.00a**       1 056.80依143.20a**       1 030.40依169.60a**  1 200.00依0.00a*
STZ+ Sildenafil        858.75依364.11a        495.00依55.17a毩        607.50依179.93a        780.25依267.32a
STZ+TMAO        878.50依186.41a         874.75依383.20a*        667.50依186.49a        787.25依214.44a
STZ+AQ100        710.00依125.60a        796.20依173.91a        505.20依36.09aA        774.40依136.73a
STZ+AQ500        710.20依139.07a        437.60依16.24aB       475.80依54.85aA        400.80依28.25aC
STZ+ETH100      779.60依92.86a       559.40依82.19aA        473.00依57.41aA        428.80依48.06aC
STZ+ETH500        869.80依143.49a        915.00依177.93a        968.40依167.03a        982.20依136.75a
Series 2 Control      476.60依24.91a      466.00依22.74a      551.00依37.83a        912.20依240.02a
STZ    1 200.00依0.00a***    1 200.00依0.00a***    1 200.00依0.00a*** 1 200.00依0.00a
STZ+ Sildenafil         945.50依148.52a*        811.25依140.34a        823.75依151.92a        925.00依173.10a
STZ+TMAO       1 104.75依95.25ad***        857.25依172.95a         678.75依178.59bB 1 200.00依0.00cd
STZ+AQ100        920.20依101.56a          758.00依115.14aA         764.60依118.23aA        959.00依149.12a
STZ+AQ500          972.20依119.95a**       738.4 0依66.56aA       766.80依11.69aA        681.40依75.53aB
STZ+ETH100      1 121.80依38.81a***           675.60依102.04bcB       740.20依98.86cA           647.20依114.42bcB
STZ+ETH500         938.00依161.35a*       1 014.20依123.34a**     1 099.00依101.00a 1 138.00依61.99a
Series 3 Control       793.60依59.95ab      568.60依70.49b       843.80依89.61ab 1 122.00依61.66ac
STZ   1 200.00依0.00a**    1 200.00依0.00a***  1 200.00依0.00a* 1 200.00依0.00a
STZ+ Sildenafil   1 200.00依0.00a**       1 045.25依106.17a**   1 151.00依49.00a 1 200.00依0.00a
STZ+TMAO   1 200.00依0.00a**         754.00依162.51bB        880.75依133.93b  1 200.00依0.00ac
STZ+AQ100     1 099.60依100.40a        1 073.60依126.40a***     1 013.60依117.50a     1 069.00依131.00a
STZ+AQ500   1 102.60依88.89a      1 110.00依82.14a***     1 072.20依116.64a   1 109.80依82.33a
STZ+ETH100      1 154.00依36.34a**       715.60依98.19a*         668.40依106.66aB        767.20依142.53a
STZ+ETH500     1 049.40依103.63a      1 161.40依38.60a***  1 200.00依0.00a* 1 200.00依0.00a
Series 4 Control   1 025.80依89.98a   1 066.80依82.12a 1 200.00依0.00a 1 200.00依0.00a
STZ  1 200.00依0.00a* 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+ Sildenafil  1 200.00依0.00a* 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+TMAO  1 200.00依0.00a*           970.00依138.11a毬     1 075.75依124.25a 1 200.00依0.00a
STZ+AQ100   1 157.80依42.20a   1 131.40依68.60a   1 108.40依91.60a   1 134.80依65.20a
STZ+AQ500  1 200.00依0.00a* 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+ETH100  1 200.00依0.00a*        951.80依122.49a      740.20依98.86a     1 028.60依947.60
STZ+ETH500  1 200.00依0.00a* 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
Series 5 Control 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+ Sildenafil 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+TMAO 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+AQ100 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+AQ500 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
STZ+ETH100 1 200.00依0.00a   1 079.00依58.94a 1 200.00依0.00a 1 200.00依0.00a
STZ+ETH500 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a 1 200.00依0.00a
Values of post-ejaculatory interval are means依SEM (n=6).
Wankeu-Nya M et al./Asian Pacific Journal of Tropical Medicine (2014)609-619 617
the penile circulation and corpora cavernosa, resulting to the 
down-regulation of the neuronal and endothelial isoforms of 
nitric-oxide synthase[12,32,33].
  Treatment of diabetic rats with sildenafil citrate, TMAO, 
aqueous (500 mg/kg) and ethanol (100 mg/kg) extracts of
D. arborea enhanced the behavioural parameters impaired 
under diabetic condition. Sildenafil citrate, a standard 
drug against erectile dysfunction (ED), was the most active 
in this study. This beneficial effect of Sidenafil citrate 
on rat copulatory activity may firstly be attributed to its 
steroidogenic activity since it was demonstrated that, 
inhibition of phosphodiesterase activity during prolonged 
sildenafil treatment increased serum testosterone level 
and Leydig cells’ steroidogenic capacity by coordinated 
stimulatory action on cyclic adenosine monophosphate 
(cAMP) and cyclic guanosine monophosphate (cGMP) 
signaling pathways[34]. Moreover, sildenafil citrate for 
erectile dysfunction is effective through an increased 
percentage of successful attempts at intercourse and 
well tolerated among men with type 1 diabetes[35]. Also, 
it is reported that acute and chronic administrations of 
sildenafil may improve endothelium-dependent cavernosal 
relaxations and erectile functions when altered by various 
pathophysiological mechanisms such as diabetes and, the 
antioxidant properties of this drug may be responsible for 
these effects[36-41]. 
  Several findings have shown that oxidative stress has a 
relevant role in the pathophysiology of diabetic erectile 
dysfunction and provides a rationale for the use of 
antioxidant therapy in the treatment of erectile dysfunction 
in diabetes[42]. Many chemicals molecules are known to 
possess antioxidant potentials responsible for the regulation 
of the endothelium dysfunction induced by oxidative stress 
through the regeneration of antioxidant enzymes[43,44]. 
Trimethylamine N-oxide (TMAO), a chemical chaperone 
used in this work could also enhanced the sexual behavior 
of diabetic rats through its antioxidant properties since 
Lupachyk and collaborators demonstrated that TMAO 
attenuated endoplasmic reticulum stress, peripheral 
nerve dysfunction, intraepidermal nerve fiber loss, and 
sciatic nerve and spinal cord oxidative-nitrative stress in 
streptozotocin diabetic rats[45].
  The enhancement of the sexual behavior observed in 
diabetic rats after D. arborea application (increase in sexual 
performance associated to a decrease of the motivation 
parameters) is indicative of the aphrodisiac potential of this 
plant[46,47]. Phenols, flavonoids, saponins and phytosterols 
revealed in these extracts, could be responsible of this sexual 
improvement. Many studies have shown that flavonoids 
and phenols are capable of relaxing the corpus cavernosum 
of both normal and diabetic rats[48-51]. Another possibility 
is that flavonoids may increase the level of testosterone, 
the main hormone that controls sexual behaviour[52,53]. As 
previously proposed in our earlier studies, sterols could 
again improve the sexual ability of the streptozotocin-
diabetic rats through an androgenic pathway[54]. Similarly, 
saponin revealed in the plant extracts, which may belong to 
the steroidal family[55], could possess an androgen increasing 
property[20,27,56]. Many other plants or plant components 
are known to improve and protect erectile tissues from the 
oxidative stress-induced degeneration via an antioxidant 
mechanism[57,58]. Results obtained in this work are similar to 
those obtained by other authors[59,60]. 
  With regard to the ejaculatory series, it appeared that 
the proposed treatments were more efficient during the 
first three ejaculatory series for both the frequency and 
latency of mounts and intromissions; this view could be 
pharmacologically explained by the exposure-response 
relationship during which a decrease in the response (effect) 
is recorded as the time is increased.
  Our results confirmed that D. arborea extracts possess 
aphrodisiac property capable of alleviating erectile 
dysfunction caused by streptozotocin-induced diabetes 
in rats without having major anti-hyperglycemic effects. 
Bioactive components such as phenols, saponins, flavonoids 
and sterols present in this plant could be useful molecules 
for the treatment of erectile dysfunction in severe diabetic 
patients; however, further investigations using long-
term diabetic rats need to be conducted in order to better 
appreciate the efficiency of this plant.
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